These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 35198598)

  • 1. Stem Cell Injection for Complex Refractory Perianal Fistulas in Crohn's Disease: A Single Center Initial Experience.
    Colombo F; Cammarata F; Baldi C; Rizzetto F; Bondurri A; Carmagnola S; Gridavilla D; Maconi G; Ardizzone S; Danelli P
    Front Surg; 2022; 9():834870. PubMed ID: 35198598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Follow-up Study to Evaluate the Long-term Safety and Efficacy of Darvadstrocel (Mesenchymal Stem Cell Treatment) in Patients With Perianal Fistulizing Crohn's Disease: ADMIRE-CD Phase 3 Randomized Controlled Trial.
    Garcia-Olmo D; Gilaberte I; Binek M; D Hoore AJL; Lindner D; Selvaggi F; Spinelli A; Panés J
    Dis Colon Rectum; 2022 May; 65(5):713-720. PubMed ID: 34890373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stem cell injection for complex anal fistula in Crohn's disease: A single-center experience.
    Schwandner O
    World J Gastroenterol; 2021 Jun; 27(24):3643-3653. PubMed ID: 34239275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Darvadstrocel for complex perianal fistulas in Crohn's disease: A systematic review and meta-analysis.
    Taxonera C; García-Brenes MA; Olivares D; López-García ON; Zapater R; Alba C
    United European Gastroenterol J; 2024 Oct; ():. PubMed ID: 39360706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesenchymal stem cell therapy for Crohn's perianal fistula-a real-world experience.
    White I; Yanai H; Avni I; Slavin M; Naftali T; Tovi S; Dotan I; Wasserberg N
    Colorectal Dis; 2024 Jan; 26(1):102-109. PubMed ID: 38095303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allogeneic expanded adipose-derived mesenchymal stem cell therapy for perianal fistulas in Crohn's disease: A case series.
    Cabalzar-Wondberg D; Turina M; Biedermann L; Rogler G; Schreiner P
    Colorectal Dis; 2021 Jun; 23(6):1444-1450. PubMed ID: 33595166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insights into treatment of complex Crohn's perianal fistulas.
    Norčič G; Smrekar N; Marković S; Barišić G; Kiudelis G; Paužas H; Molnár T; Szijarto A; Šerclová Z; Roblek T; Uršič V; White I
    BMC Proc; 2024 Apr; 18(Suppl 7):7. PubMed ID: 38658942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesenchymal stem cell therapy for therapy refractory complex Crohn's perianal fistulas: a case series.
    Pronk AJM; Beek KJ; Wildenberg ME; Bemelman WA; Stoker J; Buskens CJ
    Stem Cell Res Ther; 2024 Jun; 15(1):161. PubMed ID: 38853278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A new treatment option for complex perianal fistulas in Crohn's disease patients; development of darvadstrocel (allogeneic expanded adipose-derived mesenchymal stem cells) in Japan].
    Yamaguchi T
    Nihon Yakurigaku Zasshi; 2024; 159(3):150-155. PubMed ID: 38692877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Darvadstrocel: A Review in Treatment-Refractory Complex Perianal Fistulas in Crohn's Disease.
    Scott LJ
    BioDrugs; 2018 Dec; 32(6):627-634. PubMed ID: 30298387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Real-life effectiveness of allogeneic expanded adipose-derived mesenchymal stem cell therapy for perianal fistulizing refractory Crohn's disease.
    Alonso-Gomez M; Charlois AL; Cotte E; Gay C; Danion P; Malezieux E; Altwegg R; Boschetti G; Nancey S
    Clin Res Hepatol Gastroenterol; 2024 Nov; 48(9):102473. PubMed ID: 39349101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety of Allogeneic Adipose Tissue-Derived Mesenchymal Stem Cells for the Treatment of Complex Perianal Fistulas Not Associated With Crohn's Disease: A Phase I Clinical Trial.
    Maciel Gutiérrez VM; Gutiérrez Guillen SG; Centeno Flores MW; Valenzuela Pérez JA; Abarca Rendón FM; Hernández García FS; De la Cerda Trujillo LF; Gómez Torres GÁ
    Dis Colon Rectum; 2021 Mar; 64(3):328-334. PubMed ID: 33538521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Localized Administration of Mesenchymal Stem Cell-Derived Exosomes for the Treatment of Refractory Perianal Fistula in Crohn's Disease Patients: A Phase II Clinical Trial.
    Hadizadeh A; Akbari-Asbagh R; Heirani-Tabasi A; Soleimani M; Gorovanchi P; Ebrahimi Daryani N; Vahedi A; Nazari H; Banikarimi SP; Abbaszade-Dibavar M; Behboudi B; Fazeli MS; Keramati MR; Keshvari A; Kazemeini A; Pak H; Fazeli AR; Alborzi F; Ahmadi-Tafti SM
    Dis Colon Rectum; 2024 Sep; ():. PubMed ID: 39250316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness and safety of darvadstrocel in patients with complex perianal fistulizing Crohn's disease: a systematic review.
    Fousekis FS; Mpakogiannis K; Lianos GD; Koukoudis A; Christodoulou DK; Papaconstantinou I; Katsanos KH
    Ann Gastroenterol; 2024; 37(1):46-53. PubMed ID: 38223244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesenchymal Stromal Cell Therapy Improves Refractory Perianal Fistula in Crohn's Disease: Case Series Clinical Interventional Study.
    Vosough M; Nikfam S; Torabi SH; Sadri B; Ahmadi Amoli H; Basi A; Niknejadi M; Hossein-Khannazer N; Hosseini SE; Mardpour S; Azimian V; Jaroughi N; Aghdami N; Nikfam S; Amirzehni HR; Anushirvani A; Malekzadeh R; Baharvand H; Mohamadnejad M
    Cell J; 2022 Feb; 24(2):62-68. PubMed ID: 35279961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term Evaluation of Allogeneic Bone Marrow-derived Mesenchymal Stromal Cell Therapy for Crohn's Disease Perianal Fistulas.
    Barnhoorn MC; Wasser MNJM; Roelofs H; Maljaars PWJ; Molendijk I; Bonsing BA; Oosten LEM; Dijkstra G; van der Woude CJ; Roelen DL; Zwaginga JJ; Verspaget HW; Fibbe WE; Hommes DW; Peeters KCMJ; van der Meulen-de Jong AE
    J Crohns Colitis; 2020 Jan; 14(1):64-70. PubMed ID: 31197361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Darvadstrocel for the treatment of patients with perianal fistulas in Crohn's disease.
    Kotze PG; Spinelli A; Warusavitarne J; Di Candido F; Sahnan K; Adegbola SO; Danese S
    Drugs Today (Barc); 2019 Feb; 55(2):95-105. PubMed ID: 30816884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Darvadstrocel for the treatment of perianal fistulas in Crohn's disease.
    Meng ZW; Baumgart DC
    Expert Rev Gastroenterol Hepatol; 2020 Jun; 14(6):405-410. PubMed ID: 32354239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Phase IB/IIA Study of Ex Vivo Expanded Allogeneic Bone Marrow-Derived Mesenchymal Stem Cells for the Treatment of Perianal Fistulizing Crohn's Disease.
    Lightner AL; Reese J; Ream J; Nachand D; Jia X; Dadgar N; Steele SR; Hull T
    Dis Colon Rectum; 2023 Oct; 66(10):1359-1372. PubMed ID: 36602511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Local fistula injection of allogeneic human amnion epithelial cells is safe and well tolerated in patients with refractory complex perianal Crohn's disease: a phase I open label study with long-term follow up.
    Keung C; Nguyen TC; Lim R; Gerstenmaier A; Sievert W; Moore GT
    EBioMedicine; 2023 Dec; 98():104879. PubMed ID: 38042747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.